Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis.

× No keyword cloud information.

9 in total

Review 1. Nephrogenic systemic fibrosis in liver disease: a systematic review.

Authors: Sameer M Mazhar; Masoud Shiehmorteza; Chad A Kohl; Michael S Middleton; Claude B Sirlin
Journal: J Magn Reson Imaging Date: 2009-12 Impact factor: 4.813

Review 2. Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents.

Authors: Jeffrey G Penfield
Journal: Pediatr Nephrol Date: 2008-06-10 Impact factor: 3.714

Review 3. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.

Authors: Gautam Bhave; Julia B Lewis; Sam S Chang
Journal: J Urol Date: 2008-07-17 Impact factor: 7.450

Review 4. Gadolinium and nephrogenic systemic fibrosis: an update.

Authors: Alex Weller; Joy L Barber; Oystein E Olsen
Journal: Pediatr Nephrol Date: 2013-10-22 Impact factor: 3.714

5. Nephrogenic systemic fibrosis: current concepts.

Authors: Prasanta Basak; Stephen Jesmajian
Journal: Indian J Dermatol Date: 2011-01 Impact factor: 1.494

6. Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure.

Authors: Herwig Pieringer; Sabine Schumacher; Bernhard Schmekal; Thomas Gitter; Georg Biesenbach
Journal: NDT Plus Date: 2008-06

7. Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study.

Authors: Thomas Lauenstein; Francisco Ramirez-Garrido; Young Hoon Kim; Sung Eun Rha; Jens Ricke; Sith Phongkitkarun; Joachim Boettcher; Rajan T Gupta; Pornpim Korpraphong; Wiwatana Tanomkiat; Julia Furtner; Peter S Liu; Maren Henry; Jan Endrikat
Journal: Invest Radiol Date: 2015-06 Impact factor: 6.016

8. Gadobutrol in Renally Impaired Patients: Results of the GRIP Study.

Authors: Henrik J Michaely; Manuela Aschauer; Hannes Deutschmann; Georg Bongartz; Matthias Gutberlet; Ramona Woitek; Birgit Ertl-Wagner; Walter Kucharczyk; Renate Hammerstingl; Francesco De Cobelli; Martin Rosenberg; Thomas Balzer; Jan Endrikat
Journal: Invest Radiol Date: 2017-01 Impact factor: 6.016

9. 10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016.

Authors: Jan Endrikat; Susan Dohanish; Nicolas Schleyer; Susanne Schwenke; Sheela Agarwal; Thomas Balzer
Journal: Invest Radiol Date: 2018-09 Impact factor: 6.016

9 in total